EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study

Adam Jakubowski, Daniel Sosiński, Jerzy Robert Ładny, Marzena Wojewódzka-Żelezniakowicz

Children · 18.11.2026 · 13 (11) · 1605

DOI: 10.3390/children13111605 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Children, online erschienen am 18.11.2026. Verfasst von Adam Jakubowski und 3 weiteren Autor:innen. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The European Resuscitation Council (ERC) Guidelines 2025 Paediatric Life Support prefer ideal body weight (IBW) for hydrophilic drugs and no longer explicitly recommend pre-calculated dose aids.

Objective

To examine what the guidelines state and cite, the evidence, and resulting dose differences.

Methods

An exploratory study combining a document analysis of the ERC paediatric guidelines 2015–2025 and 20 comparator documents; a structured, non-systematic evidence review; and a deterministic calculation, from World Health Organization growth references (2–15 years), of total body weight (TBW) at −2 to +3 standard deviations (SD) of body mass index-for-age relative to IBW.

Results

The IBW statement (explanatory text only) has no reference, method or threshold; recommended estimation methods return TBW. At 2–10 years, TBW-based doses exceeded IBW-based doses by 18–36% at +2 SD and 28–71% at +3 SD (up to 40% and 78% at 11–15 years); at −2 SD they were 14–22% lower. These are differences between intended doses, not administration errors. Our searches identified no pharmacokinetic study of adrenaline in children with obesity, no comparison of dosing scalars and no study showing harm from such differences. Explicit pre-calculated dose advice (2021) gave way, unlisted among the changes, to a system-level recommendation of standardised drug calculations and cognitive aids, which the guideline retains. In two before–after evaluations of one dosing ruler, threefold deviations fell from 22.0% to 2.2% and 9.9%; deviations above 20% did not.

Conclusions

For children with obesity aged 2–10 years, the guideline points to two dosing weights differing by about 20–70%; within the limits of a non-systematic search, we found no pharmacokinetic or outcome data favouring either. Guideline groups may wish to consider referencing or withdrawing the statement, defining any retained IBW method and naming pre-calculated, volume-based dose aids.

Zitieren

APA

Jakubowski, A., Sosiński, D., Ładny, J. R., & Wojewódzka-Żelezniakowicz, M. (2026). Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study. Children, 13(11), 1605. https://doi.org/10.3390/children13111605

Vancouver

Jakubowski A, Sosiński D, Ładny JR, Wojewódzka-Żelezniakowicz M. Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study. Children. 2026;13(11):1605. doi:10.3390/children13111605

BibTeX
@article{Jakubowski2026,
  author = {Jakubowski, Adam and Sosiński, Daniel and Ładny, Jerzy Robert and Wojewódzka-Żelezniakowicz, Marzena},
  title = {Dosing Weight and Pre-Calculated Dose Aids in the European Resuscitation Council Guidelines 2025 Paediatric Life Support: A Document Analysis, Evidence Review and Reference-Chart Modelling Study},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {1605},
  doi = {10.3390/children13111605}
}
Kostenlos starten →